SCHEMBL4897981

SCHEMBL4897981

Cc1sc(-c2cccc(-n3cccc3)c2)nc1CCO

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DCK P27707 2/20 0.38
GAA P10253 1/20 0.37
PPARG P37231 7/20 0.36
PPARA Q07869 7/20 0.36
AOC2 O75106 1/20 0.36
HRH3 Q9Y5N1 3/20 0.34
FFAR4 Q5NUL3 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
DUSP3 P51452 1/20 0.34
PTPN5 P54829 1/20 0.34
KMT2A Q03164 1/20 0.34
PTPN11 Q06124 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
PDE10A Q9Y233 1/20 0.33
RARA P10276 1/20 0.33
RARB P10826 1/20 0.33
RARG P13631 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906756 0.88 DCK (0.41) DCKGAAPPARGPPARAAOC2
SCHEMBL1436666 0.81 PPARG (0.48) DCKPPARGPPARAMEN1POLB
SCHEMBL6697513 0.80 PPARG (0.44) DCKPPARGPPARAMEN1KMT2A
SCHEMBL4906239 0.80 TRPM8 (0.46) GAAMEN1KMT2ARARARARB
SCHEMBL1436076 0.78 RARA (0.50) GAAPPARGPPARAHRH3PDE10A
SCHEMBL4889434 0.76 RARA (0.51) GAAPPARGPPARAHRH3RARA
SCHEMBL4906632 0.75 PPARG (0.39) DCKPPARGPPARARARARARB
SCHEMBL4904262 0.73 LMNA (0.45) KDM4EPOLBPDE10A
SCHEMBL4900770 0.73 LMNA (0.38) PPARGPPARAPDE10A
SCHEMBL3371722 0.72 PPARA (0.39) DCKPPARGPPARAPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD DCK 3882/4885GAA 1383/4885PPARG 2/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD DCK 3976/4885GAA 1367/4885PPARG 2/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD DCK 3976/4885GAA 1367/4885PPARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.